Hydrogenology
Source-linked study record

The Role of Mast Cells in the Remodeling Effects of Molecular Hydrogen on the Lung Local Tissue Microenvironment under Simulated Pulmonary Hypertension

Atiakshin D, Kostin A, Alekhnovich A, Volodkin A, Ignatyuk M, Klabukov I, Baranovskii D, Buchwalow I, Tiemann M, Artemieva M, Medvedeva N, LeBaron TW, Noda M, Medvedev O. · International journal of molecular sciences. 2024;25(20):11010.

PreclinicalInhaled H₂Published 2024Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

rats, tissue, cell, cells used to study cardiovascular and circulatory health.

Intervention and dose

Full text reports inhaled H₂-containing gas. Detected intervention quantities or schedules: 4%, 21 days, 0.15 L/min, 4 L/min, 4.0%. · H₂-related quantities reported in the intervention passages: 4%, 21 days, 0.15 L/min, 4 L/min, 4.0%. Values are not combined across different experimental arms.

Duration

21 days

Reported result

Article-reported result excerpt (24 words maximum): “Overall, using H_2 reduced the inflammatory changes in the lungs induced by MCT, which correlated with the suppression of the proinflammatory effect of the…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Main limitation

Preclinical evidence only; findings do not establish a treatment effect in people. Funding or grant information is reported in the full article. The article declares no conflicts of interest.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Controlled animal and cell study

Research topic

Cardiovascular and circulatory health

Administration form

Inhaled H₂

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

rats, tissue, cell, cells used to study cardiovascular and circulatory health.

Sample

Preclinical study; group or assay counts reported in the full text include n=8.

Duration

21 days

Intervention

Full text reports inhaled H₂-containing gas. Detected intervention quantities or schedules: 4%, 21 days, 0.15 L/min, 4 L/min, 4.0%.

Hydrogen form

Inhaled molecular H₂ at 4%; not classified as Brown’s gas without an H₂/O₂ composition.

Dose or H₂ specification

H₂-related quantities reported in the intervention passages: 4%, 21 days, 0.15 L/min, 4 L/min, 4.0%. Values are not combined across different experimental arms.

H₂ flow

6 mL/min H₂, calculated from 4% H₂ and 150 mL/min total flow reported in the full text.

O₂ delivered with H₂

O₂ concentration and absolute O₂ flow were not both reported in the full article; no value is inferred.

Comparator

Control or comparison condition reported in the full article; see the linked methods for arm-specific details.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

survival or mortality, clinical symptoms or functional scores, tumor growth or cancer markers, inflammation and cytokines, oxidative-stress and antioxidant markers, apoptosis or cell injury

Reported result

Article-reported result excerpt (24 words maximum): “Overall, using H_2 reduced the inflammatory changes in the lungs induced by MCT, which correlated with the suppression of the proinflammatory effect of the…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Extraction completeness

The complete machine-readable article was checked for source identity, methods, intervention quantities, results, tables, funding and conflict declarations. This public record is based on the full article.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Preclinical evidence only; findings do not establish a treatment effect in people. Funding or grant information is reported in the full article. The article declares no conflicts of interest.

Applies directly to

Applies to the reported animal, cell or tissue model, not directly to patients.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 39456794 · DOI: 10.3390/ijms252011010

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official Europe PMC JATS full article and PubMed/PMC identifiers; structured full-text extraction and validation completed 8 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.